ArticleCancer research communications2022

Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer.

Joel R Eisner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.